Related Experiment Video
Updated: Aug 5, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Contribution of Interstitial Lung Disease to Mortality in Patients With Connective Tissue Diseases
Atefeh Vaezi1, Tracy Ashby1, Arvind Balavenkataraman1
1Division of Pulmonary, Critical Care, and Sleep Medicine, College of Medicine-Jacksonville, University of Florida, Jacksonville, FL.
Background:
Interstitial lung diseases (ILDs) are common in patients with connective tissue diseases (CTDs), but their role in the mortality of patients with CTDs remains unexplored.
Research Question:
What proportion of mortality in patients with CTDs is due to ILD?
Study Design And Methods:
In this retrospective, population-based epidemiologic study, we used the Wide-Ranging Online Data for Epidemiologic Research database and extracted mortality data of all deceased US citizens aged ≥ 15 years, from 1999 to 2019. Age-adjusted mortality rate (AAMR) was calculated by sex, racial group, and state of death. The annual trend was examined using the annual percent change and average annual percent change. We identified the rank of ILD as an underlying cause of death compared with the 15 leading causes of death in patients with CTDs.
Results:
From 1999 to 2019, CTDs were mentioned in the death certificates of 286,643 US citizens, with 26,406 (7.12%) of them having ILDs simultaneously. The ILD-CTD-related AAMR per 1 million population decreased from 4.26 in 1999 to 3.37 in 2015 and further increased to 4.03 in 2019. The ILD-CTD-related AAMRs during 1999 to 2019 for female individuals and male individuals were 4.53 and 2.80 per 1 million, respectively. In the list of 15 leading causes of mortality, ILD could be ranked as the seventh, 11th, third, fourth, and fourth cause of death in patients with rheumatoid arthritis, systemic lupus erythematosus, polymyositis/dermatomyositis, systemic sclerosis, and Sjögren syndrome, respectively.
Interpretation:
Our findings underscore the necessity for developing screening protocols and targeted interventions aimed at reducing ILD-related mortality in patients with CTD. This could significantly improve outcomes and quality of life for these patients.
Related Concept Videos
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Other Pulmonary Disorders
Chronic Obstructive Pulmonary Disease I: Introduction